For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.
Limited to conditions with 5 or more bacteria
| Name | Overlap Percent | Prevalance in Population | Matches | Bacteria in From | Bacteria in To |
|---|---|---|---|---|---|
| Alzheimer's disease | 27.3 % | 10% | 6 | 50 | 22 |
| Autism | 59.1 % | 2% | 13 | 110 | 22 |
| Ulcerative colitis | 31.8 % | 0.1% | 7 | 108 | 22 |
| Allergies | 18.2 % | 30% | 4 | 50 | 22 |
| Schizophrenia | 31.8 % | 0.75% | 7 | 93 | 22 |
| Mood Disorders | 50 % | 29.7% | 3 | 6 | 22 |
| Ankylosing spondylitis | 54.5 % | 7% | 12 | 520 | 22 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 54.5 % | 0.86% | 12 | 134 | 22 |
| Multiple Sclerosis | 36.4 % | 0.5% | 8 | 100 | 22 |
| Obesity | 27.3 % | 42.4% | 6 | 104 | 22 |
| neuropsychiatric disorders (PANDAS, PANS) | 13.3 % | 0.1% | 2 | 15 | 22 |
| Obesity | 22.7 % | 42.4% | 5 | 55 | 22 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 13.6 % | 0.005% | 3 | 43 | 22 |
| Metabolic Syndrome | 14.3 % | 21% | 1 | 7 | 22 |
| ME/CFS with IBS | 15.8 % | 2.8% | 3 | 19 | 22 |
| Liver Cirrhosis | 63.6 % | 0.27% | 14 | 678 | 22 |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 36.4 % | 25% | 8 | 76 | 22 |
| Systemic Lupus Erythematosus | 27.3 % | 0.15% | 6 | 66 | 22 |
| Depression | 45.5 % | 8% | 10 | 81 | 22 |
| Parkinson's Disease | 40.9 % | 1% | 9 | 90 | 22 |
| IgA nephropathy (IgAN) | 13.6 % | 0.001% | 3 | 29 | 22 |
| Insomnia | 30 % | 30% | 3 | 10 | 22 |
| hypertension (High Blood Pressure | 33.3 % | 47% | 2 | 6 | 22 |
| Irritable Bowel Syndrome | 45.5 % | 15% | 10 | 62 | 22 |
| gallstone disease (gsd) | 20 % | 5% | 3 | 15 | 22 |
| Chronic Urticaria (Hives) | 13.6 % | 5% | 3 | 23 | 22 |
| Functional constipation / chronic idiopathic constipation | 18.2 % | 14% | 4 | 41 | 22 |
| Epilepsy | 13.6 % | 0.84% | 3 | 25 | 22 |
| Fibromyalgia | 22.7 % | 1.12% | 5 | 37 | 22 |
| Inflammatory Bowel Disease | 31.8 % | 1.3% | 7 | 66 | 22 |
| Type 1 Diabetes | 31.8 % | 0.19% | 7 | 52 | 22 |
| Cerebral Palsy | 23.5 % | 0.2% | 4 | 17 | 22 |
| Colorectal Cancer | 18.2 % | 4.3% | 4 | 296 | 22 |
| Chronic Fatigue Syndrome | 22.7 % | 3% | 5 | 55 | 22 |
| Celiac Disease | 18.2 % | 1.4% | 4 | 67 | 22 |
| Carcinoma | 18.2 % | 1% | 4 | 51 | 22 |
| Asthma | 22.7 % | 8% | 5 | 27 | 22 |
| Atherosclerosis | 45.5 % | 50% | 10 | 524 | 22 |
| Acne | 10.5 % | 47% | 2 | 19 | 22 |
| Crohn's Disease | 54.5 % | 0.3% | 12 | 141 | 22 |
| Sjögren syndrome | 22.7 % | 1.2% | 5 | 41 | 22 |
| Stress / posttraumatic stress disorder | 18.2 % | 5.2% | 4 | 56 | 22 |
| Type 2 Diabetes | 68.2 % | 10.8% | 15 | 267 | 22 |
| ADHD | 27.3 % | 9.4% | 6 | 47 | 22 |
| Hashimoto's thyroiditis | 21.4 % | 0.35% | 3 | 14 | 22 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.